20,000 postop patient of various surgeries were compared to each other. The key word is cure and reduction to provide a control to the disease of diabetes. From data finalized in this research of 13 years follow-up of postops, there was a 98.9% improvement with the contribution of the DS, compared with 83.7% with RnY and 47.9% with Lapband.
Bariatric Surgery
A Systematic Review and Meta-analysis
Henry Buchwald MD
JAMA
October 13, 2004
Vol 292, No. 14
source where I obtained info from:
http://jama.ama-assn.org/cgi/content/abstract/292/14/1724
http://jama.ama-assn.org/cgi/reprint/292/24/3040.pdf
http://jama.ama-assn.org/cgi/content/full/jama;293/14/1728-b
Below is a chart outlining the differences following weight loss surgery in the cure and or reduction of diabetes and other serious morbid obesity related diseases reported by Harvey Buchwald, M.D. in his meta analysis published in 2004. In this study over 20,000 postoperative bariatric patients were followed for up to 13 years.
Obesity Related Illnesses that Improved/Resolved Following Weight Loss Surgery:
Gastric Band RNY DS
Diabetes Mellitus 47.9% 83.7% 98.9%
Hyperlipidemia 58.9% 96.9% 99.1%
Hypertension 43.2% 67.5% 83.4%
Sleep Apnea 95% 80.4% 92%
From Page 7
Cormorbidity Outcomes
Diabetes. When defined as the ability to discontinue all diabetes-related medications and maintain blood glucose levels within the normal range, strong evidence for improvement in type 2 diabetes and impaired glucose tolerance was found across all surgery types. Within studies reporting resolution of diabetes, 1417 (76.8% [meta-analytic mean, 76.8%; 95% CI, 70.7%-82.9%]) of 1846 patients experienced complete resolution. Within studies reporting both resolution and improvement or only improvement of diabetes, 414 (85.4% [meta-analytic mean, 86.0%;95% CI, 78.4%-93.7%]) of 485 (mean change, 71.53 mg/dL; 95% CI, 49.37%-93.69 mg/dL [3.97 mmol/L; 95% CI, 2.74-5.2 mmol/L]; n=296 by meta-analysis) compared with unselected populations (means change, 13.33 mg/dL; 95% CI, 10.81-15.86 mg/dL [0.74 mmol/L; 95% CI, 0.60-0.88 mmol/L]; n-2092 by meta-analysis.
There was a difference in diabetes outcomes analyzed according to the 4 categories of operative procedures. With respect to diabetes resolution, there was a gradation of effect from
98.9% (95% CI, 96.8%-100%) for bioliopancreatic diversion or duodenal switch to
83.7% (95% CI, 77.3%-90.1%) for gastric bypass to
71.6% (95%CI; 55.1%-88.2%) for gastroplasty, and to
47.9 (95% CI, 29.1%-66.7%) for gastric banding.
The percentage of patients with diabetes resolved or improved showed different results (Table 5 [page 9]); this variation from the trend solely for diabetes resolved may be due to the far greater number of patients assessed for this variable (n=85) in the total population.
From Page 10
Resolution of diabetes often occurred days following bariatric surgery, even before marked weight loss was achieved. Resolution of diabetes was more prevalent following the predominantly malabsorptive procedures (bioliopancreatic diversion or duodenal switch) and the mixed/restrictive gastric bypass in contrast to the purely restrictive gastroplasty and gastric banding procedures. In addition, there appeared to be a gradation of diabetes resolution as a function of the operative procedure itself.
98.9% for bioliopancreatic diversion or duodenal switch
83.7% for gastric bypass
71.6% for gastroplasty, and
47.9% for gastric banding.
The putative extent and time relationship of the different operative procedures to diabetes resolution or improvement after bariatric surgery may be related to some of the changes in the gut related hormones. The hormonal milieu, or the relative balance of forgut mediators, is differently affected when the distal stomach is bypass, or a partial gastrectomy is performed, and the enteric contents are separated from the bioliopancreatic stream in the upper small intestinal tract. The study of the impact of the various bariatric procedures on leptin, grehlin, resistin, acylation-stimulating protein, adiponectin, entro-glucagon, cholecystokin, and other gastrointestinal satiety mediators receiving increasing attention.
Duodenal Switch
I would like to share my personal post-op experiences, fact based knowledge and background regarding my surgery which is a combination of the Vertical Sleeve Gastrectomy (VSG) and Duodenal Switch (DS), performed under 1 surgical procedure. It is medically known as a a gastric restriction with partial gastrectomy, pylorus-preserving duodenoileostomy and ileoileostomy to limit absorption. It is known by its formality as a bilio-pancreatic diversion with duodenal switch and abbreviated as BPD/DS or DS. A not so wordy way to say it is sleeve gastrectomy with duodenal switch or just the DS.
I had my laparoscopic duodenal switch procedure on Nov 14th, 2006 for the surgical medical treatment of morbid obesity that can kill you. I am still the same person within, only my outer shell has morph to what I once looked like before this disease imprisoned me. The most important thing that matters is, I have my health back and that means more to me than the actual weight loss.
What is your body if you are not healthy with your respiratory, circulatory, cardiac and digestive system working properly and have mobility to be able to do things on your own, independently with no limitations, no complications or becoming a fatality?
This is what bariatric surgery outcome has done for me, give me my health as well as my life back!
The Duodenal Switch (DS)
The DS procedure has been performed since 1988 and combines restrictive and malabsorptive elements to help achieve and maintain long-term weight loss:
1. by restricting the amount of food that can be eaten through a reduction in stomach size
2. limit the amount of food that is absorbed into the body through a rerouting of the intestines
3. have a metabolic effect induced by manipulating intestinal hormones as a result of intestinal rerouting
The overall effect is that DS patients are able to engage in fairly normal, free eating, while having the benefit of taking on the metabolism of a lean individual.
I had my laparoscopic duodenal switch procedure on Nov 14th, 2006 for the surgical medical treatment of morbid obesity that can kill you. I am still the same person within, only my outer shell has morph to what I once looked like before this disease imprisoned me. The most important thing that matters is, I have my health back and that means more to me than the actual weight loss.
What is your body if you are not healthy with your respiratory, circulatory, cardiac and digestive system working properly and have mobility to be able to do things on your own, independently with no limitations, no complications or becoming a fatality?
This is what bariatric surgery outcome has done for me, give me my health as well as my life back!
The Duodenal Switch (DS)
The DS procedure has been performed since 1988 and combines restrictive and malabsorptive elements to help achieve and maintain long-term weight loss:
1. by restricting the amount of food that can be eaten through a reduction in stomach size
2. limit the amount of food that is absorbed into the body through a rerouting of the intestines
3. have a metabolic effect induced by manipulating intestinal hormones as a result of intestinal rerouting
The overall effect is that DS patients are able to engage in fairly normal, free eating, while having the benefit of taking on the metabolism of a lean individual.